Added Value of Whole-Body Diffusion-Weighted Imaging in Patients Undergoing Prostate-Specific Membrane Antigen Positron Emission Tomography is a research paper published in Journal of Clinical Medicine (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Clovis Oncology, GE Healthcare, Lantheus, Janssen, Novartis, Telix Pharmaceuticals, the Prostate Cancer Foundation, and the National Cancer Institute
Grant: R01CA235741
Clovis Oncology, GE Healthcare, Lantheus, Janssen, Novartis, Telix Pharmaceuticals, the Prostate Cancer Foundation, and the National Cancer Institute
Grant: R01CA212148
Clovis Oncology, GE Healthcare, Lantheus, Janssen, Novartis, Telix Pharmaceuticals, the Prostate Cancer Foundation, and the National Cancer Institute
Grant: UL1 TR001872
NIH HHS
Grant: R01CA235741, R01CA212148
National Institutes of Health
Grant: 1R01CA235741-01A1
MELT: Modulation of PSMA Expression for Lutetium Therapy
National Institutes of Health
Grant: 5UL1TR001872-02
Clinical and Translational Science Institute
National Institutes of Health
Grant: 1R01CA212148-01
Qualification and Harmonization of PET/MRI for Cancer Clinical Trials
FWCI
0.78
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords